The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preliminary activity and safety results of KRAS G12C inhibitor glecirasib (JAB-21822) in patients with pancreatic cancer and other solid tumors.
 
Jian Li
No Relationships to Disclose
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Yanhong Gu
No Relationships to Disclose
 
Antonio Calles
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Takeda
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; IGEN BIOTECH; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche/Genentech; Sanofi/Regeneron; Takeda
Research Funding - MSD Oncology
Travel, Accommodations, Expenses - Boehringer Ingelheim; MSD Oncology; Pfizer
 
Lin Wu
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Hengrui Medicine; Innovate Biopharmaceuticals; Lilly; MSD; Pfizer; Roche China
 
Yi Ba
No Relationships to Disclose
 
Zhi-hua Li
No Relationships to Disclose
 
Chunmei Bai
No Relationships to Disclose
 
Yu Yao
No Relationships to Disclose
 
Ayala Hubert
No Relationships to Disclose
 
Julia Martinez Perez
No Relationships to Disclose
 
Jon Zugazagoitia
Honoraria - AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Guardant Health; NanoString Technologies; Pfizer; Roche/Genentech; Sanofi/Regeneron
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; Novartis; Novartis; Pfizer; Sanofi/Regeneron
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb/Celgene; Guardant Health; MSD Oncology; NanoString Technologies; Pfizer; Roche
Research Funding - AstraZeneca (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Roche/Genentech
 
Yuli Ding
Employment - Jacobio
 
Sumei Liu
Employment - Jacobio
 
Zhiyue Rao
Employment - Jacobio
 
Zhiwen He
No Relationships to Disclose